Distribution of antibodies to selected antigens of Pseudomonas aeruginosa in children and young adults with cystic fibrosis.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 24964236)

Published in Pneumonol Alergol Pol on January 01, 2014

Authors

Józef Gaweł1, Andrzej Pogorzelski, Ewa Działek-Smętek, Beata Sochań, Renata Ligarska, Maria Lącka, Henryk Mazurek

Author Affiliations

1: jgawel@igrabka.edu.pl.

Articles by these authors

Mutations in radial spoke head genes and ultrastructural cilia defects in East-European cohort of primary ciliary dyskinesia patients. PLoS One (2012) 1.02

Gene expression studies in cells from primary ciliary dyskinesia patients identify 208 potential ciliary genes. Hum Genet (2010) 0.91

Sequence analysis of 21 genes located in the Kartagener syndrome linkage region on chromosome 15q. Eur J Hum Genet (2008) 0.90

Normal values for maximal static inspiratory and expiratory pressures in healthy children. Pediatr Pulmonol (2002) 0.88

Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis. Scand J Clin Lab Invest (2010) 0.88

RPGR mutations might cause reduced orientation of respiratory cilia. Pediatr Pulmonol (2012) 0.87

Cystic fibrosis is a risk factor for celiac disease. Acta Biochim Pol (2010) 0.86

Population specificity of the DNAI1 gene mutation spectrum in primary ciliary dyskinesia (PCD). Respir Res (2010) 0.84

A formulation of aerosolized tobramycin (Bramitob) in the treatment of patients with cystic fibrosis and Pseudomonas aeruginosa infection: a double-blind, placebo-controlled, multicenter study. Paediatr Drugs (2007) 0.84

Fecal elastase-1 cut-off levels in the assessment of exocrine pancreatic function in cystic fibrosis. J Cyst Fibros (2002) 0.83

Impulse oscillometry vs. body plethysmography in assessing respiratory resistance in children. Pediatr Pulmonol (2006) 0.81

Carrier status for 3 most frequent CFTR mutations in Polish PCD/KS patients: lack of association with the primary ciliary dyskinesia phenotype. J Appl Genet (2007) 0.80

[Is prediction of the allergic march possible on the basis of nasal cytology?]. Pneumonol Alergol Pol (2010) 0.80

[Validation of Polish version of CFQoL in patients with cystic fibrosis]. Pol Merkur Lekarski (2007) 0.79

[The influence of medical treatment of the perennial allergic rhinitis on the adenoid size in children]. Otolaryngol Pol (2006) 0.78

Mild CFTR mutations and genetic predisposition to lactase persistence in cystic fibrosis. Eur J Hum Genet (2011) 0.78

[Vitamin K deficiency in patients with CF despite supplementation]. Med Wieku Rozwoj (2010) 0.77

Reference values for forced inspiratory flows in children aged 7-15 years. Pediatr Pulmonol (2004) 0.76

Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth. J Cyst Fibros (2011) 0.75

[CFQoL questionnaire as an assessment tool of quality of life in patients with cystic fibrosis]. Pol Merkur Lekarski (2007) 0.75

[Allergic tonsillitis: myth or reality]. Postepy Hig Med Dosw (Online) (2005) 0.75

[Nasal provocation test with lysine-aspirin in diagnosis of nonallergic rhinitis with eosinophilia]. Otolaryngol Pol (2006) 0.75

Macrolide antibiotics in respiratory diseases. Recommendations of the Polish Expert Group - AD 2015. Pneumonol Alergol Pol (2016) 0.75

Problems of patients with cystic fibrosis during transition to adulthood. Pneumonol Alergol Pol (2015) 0.75

[The analysis of incidence of adenoid hypertrophy in children hypersensitive to dust mites]. Otolaryngol Pol (2006) 0.75

Serum Phospholipid Fatty Acid Composition in Cystic Fibrosis Patients with and without Liver Cirrhosis. Ann Nutr Metab (2017) 0.75

Prevalence of Helicobacter pylori infection in patients with cystic fibrosis. J Cyst Fibros (2013) 0.75

[Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part I. Mechanisms of actions and clinical effectiveness of treatment in children with asthma]. Pol Merkur Lekarski (2004) 0.75

[Control of asthma symptoms and cellular markers of inflammation in induced sputum in children and adolescents with chronic asthma]. Pol Merkur Lekarski (2009) 0.75

[Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children]. Pol Merkur Lekarski (2004) 0.75

Patient's perception of the meaning of life in cystic fibrosis--its evaluation with respect to the stage of the disease and treatment. Postepy Hig Med Dosw (Online) (2012) 0.75

Antibiotic therapy and fat digestion and absorption in cystic fibrosis. Acta Biochim Pol (2011) 0.75

[Echocardiographic assessment of cor pulmonale in patients with cystic fibrosis]. Wiad Lek (2006) 0.75

[The results of extra diagnostic methods in patients allergic to dust mites treated by specific immunotherapy]. Przegl Lek (2005) 0.75